StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.73+0.02 (+0.05%)

Close on Nov 18, 2026Market cap $27.98BP/E –Yield –

Roivant Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Roivant Sciences's price to sales ratio was 444.3× on Sep 30, 2025, against 235.5× a year earlier. Over the last 4 years it ranged from 41.7× to 444.3×, with a median of 135.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Sep 30, 2025444.3×+210.1
2024Dec 31, 2024234.2×+105.1
2023Dec 29, 2023129.0×+17.4
2022Dec 30, 2022111.6×−50.3
2021Dec 31, 2021162.0×–

More Roivant Sciences figures

See a number that looks wrong?